ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Ankylosing spondylitis (AS)"

  • Abstract Number: 605 • 2018 ACR/ARHP Annual Meeting

    Clinical Outcomes of Golimumab As Second Line TNF Inhibitor Treatment in Patients with Rheumatoid Arthritis (RA), Psoriatic Arthritis (PsA) or Ankylosing Spondylitis (AS) – Subanalysis of a Non-Interventional Study in Germany

    Klaus Krüger1, Gerd R. Burmester2, Siegfried Wassenberg3, Astrid Thiele4 and Matthias H. Thomas5, 1Medical Centre of Rheumatology, Munich, Germany, 2Rheumatology and Clinical Immunology, Charité-University Medicine Berlin, Berlin, Germany, 3Rheumazentrum Ratingen, Ratingen, Germany, 4Krankenhaus St. Josef Wuppertal, Wuppertal, Germany, 5Medical Affairs, MSD Sharp & Dohme GmbH, Bünde, Germany

    Background/Purpose: Golimumab (GLM) has demonstrated efficacy and safety in patients (pts.) with active RA after treatment with at least one TNFi in a RCT. However,…
  • Abstract Number: 897 • 2018 ACR/ARHP Annual Meeting

    Prevalence of Inflammatory and Chronic Changes Suggestive of Axial Spondyloarthritis in Magnetic Resonance Images of the Axial Skeleton in Individuals < 45 Years in the General Populationas Part of a Large Community Study (SHIP)

    Xenofon Baraliakos1, Daniel Feldmann2, Anne Ott2, Carsten Oliver Schmidt3, Martin Albers3, Adrian Richter3 and Jürgen Braun1, 1Ruhr-University Bochum, Herne, Germany, 2Rheumazentrum Ruhrgebiet, Herne, Germany, 3Institute for Community Medicine, University Medicine Greifswald, Greifswald, Germany

    Background/Purpose: Magnetic resonance imaging (MRI) is crucial for classification and diagnosis of axial spondyloarthritis (axSpA). Characteristic MRI lesions of axSpA are bone marrow edema (BME)…
  • Abstract Number: 1634 • 2018 ACR/ARHP Annual Meeting

    The Impact of Comorbidities on Physical Function in Patients with Ankylosing Spondylitis and Psoriatic Arthritis Attending Rheumatology Clinics. Results of a National Study

    Cristina Fernández-Carballido1, Maria Auxiliadora Martin2, María Carmen García-Gómez3, Santos Castañeda4, Carlos González-Juanatey5, Fernando Sánchez-Alonso6, Rosario García-Vicuña7, Celia Erausquin8, Francisco J Lopez-Longo9, María D Sanchez-Gonzalez10, Alfonso Corrales11, Estefania Quesda-Masachs12, Eugenio Chamizo Carmona13, Carmen Barbadillo14, Javier Bachiller15, Tatiana Cobo-Ibáñez16, Ana Turrión Nieves17, Emilio Giner Serret18, Javier Llorca19 and Miguel Angel González-Gay11, 1Rheumatology Division, Hospital General Universitario de Elda, Elda, Spain, 2Research Unit of Spanish Society of Rheumatology,, Madrid, Spain, 3Rheumatology Division, Consorci Sanitari de Terrassa, Terrassa (Barcelona), Spain, 4Hospital Universitario La Princesa, IIS-Princesa, Madrid, Spain, 5Division of Cardiology, Hospital Universitario Lucus Augusti, Lugo, Spain, 6Unidad de Investigación, Spanish Society of Rheumatology, Madrid, Spain, 7Rheumatology, Hospital Universitario de La Princesa. IIS La Princesa, Madrid, Spain, 8Rheumatology, Hospital de Gran Canaria Dr Negrin, Las Palmas GC, Spain, 9Rheumatology Department, Hospital Gregorio Marañón, Madrid, Spain, 10Rheumatology, Hospital Clínico, Salamanca, Spain, 11Rheumatology, Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Universidad de Cantabria. Spain, Santander, Spain, 12Rheumatology Division, Hospital Vall Hebrón, Barcelona, Spain, 13Rheumatology, Hospital de Mérida, Merida, Spain, 14Hospital Universitario Puerta de Hierro, Madrid, Spain, 15Immuno-Rheumatology research group, IRYCIS. Ramón y Cajal University Hospital, Madrid, Spain, 16Hospital Universitario Reina Sofía, Universidad Europea de Madrid, Madrid, Spain, 17Rheumatology, Hospital Universitario de Salamanca. Spain, Salamanca, Spain, 18Rheumatology, H Obispo Polanco, Teruel, Spain, 19Department of Epidemiology and Computational Biology, School of Medicine, University of Cantabria, and CIBER Epidemiología y Salud Pública (CIBERESP), IDIVAL, Santander, Spain, Santander, Spain

    Background/Purpose: Functional status gets worse with comorbidities regardless of disease activity in patients with rheumatoid arthritis (RA). However, the impact of comorbidities on physical function…
  • Abstract Number: 2580 • 2018 ACR/ARHP Annual Meeting

    Predicting Treatment Persistence and Non-Persistence of Newly Initiated TNF Inhibitor Therapy in Ankylosing Spondylitis Patients: A Gender Comparison

    Theresa Hunter1, Atul A. Deodhar2, Rebecca Bolce1, Krista Schroeder1 and David Sandoval Calderon1, 1Eli Lilly and Company, Indianapolis, IN, 2Oregon Health & Science U, Portland, OR

    Background/Purpose: The purpose of this study was to compare treatment patterns in the 2 years following the initiation of TNF inhibitor (TNFi) in AS patients.Methods:…
  • Abstract Number: 645 • 2018 ACR/ARHP Annual Meeting

    Real World Secukinumab Study in Ankylosing Spondylitis and Psoriatic Arthritis – Comorbidities and Extraarticular Manifestations: Incidence and Status throughout a Non-Interventional Study in Germany

    Uta Kiltz1, Peter Kaestner2, Holger Krauel2, Ilka Schwarze3, Jan Brandt-Juergens4, Monika Maier-Peuschel5, Carolin Legeler5, Justyna Veit5 and Hans-Peter Tony6, 1Rheumazentrum Ruhrgebiet, Herne, Germany, 2Rheumatology, Ambulantes Rheumazentrum, Erfurt, Germany, 3Praxis internistische Rheumatologie, Leipzig, Germany, 4Rheumatology, Rheumatologische Schwerpunktpraxis, Berlin, Germany, 5Novartis Pharma GmbH, Nürnberg, Germany, 6Rheumatology/Immunology, Medizinische Klinik II, Universitätsklinik, Würzburg, Germany

    Background/Purpose: Patients with psoriatic arthritis (PsA) or ankylosing spondylitis (AS) may suffer from extraarticular (EA) manifestations (uveitis, psoriasis) and have higher rates of comorbidities like…
  • Abstract Number: 1143 • 2018 ACR/ARHP Annual Meeting

    Periodontal Disease Is Associated with an Increased Risk of Ankylosing Spondylitis: A Systematic Review and Meta-Analysis

    Patompong Ungprasert1, Karn Wijarnpreecha2 and Wisit Cheungpasitporn3, 1Clinical Epidemiology Unit, Department of Research and Development, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand, 2Internal medicine, Bassett medical center, cooperstown, NY, 3Medicine, University of Mississippi Medical center, Jackson, MS

    Periodontal Disease is Associated with an Increased Risk of Ankylosing Spondylitis: A Systematic Review and Meta-analysisAbstractBackground/Purpose: The association between periodontal disease and rheumatoid arthritis is…
  • Abstract Number: 1638 • 2018 ACR/ARHP Annual Meeting

    Impact of Extra-Articular Manifestations on Patient-Reported Outcomes in Ankylosing Spondylitis and Psoriatic Arthritis: Interim Results from the Complete Studies

    Louis Bessette1, Majed Khraishi2,3, Brandusa Florica4, Yatish Setty5, Michelle Teo6 and Valencia P. Remple7, 1Centre Hospitalier de l'Université Laval, Quebec, QC, Canada, 2Memorial University of Newfoundland, St. John's, NF, Canada, 3Nexus Clinical Research, Memorial University of Newfoundland, St Johns, NF, Canada, 4University of Toronto, Toronto, ON, Canada, 5Grey Bruce Health Services, Owen Sound, ON, Canada, 6University of British Columbia, Penticton, BC, Canada, 7AbbVie Corporation, Montreal, QC, Canada

    Background/Purpose: Extra-articular manifestations (EAMs) in rheumatic diseases have been previously found to negatively impact health outcomes including quality of life and work capacity. Even though…
  • Abstract Number: 2584 • 2018 ACR/ARHP Annual Meeting

    Low Incidence of Both New-Onset and Flares of Uveitis in Secukinumab-Treated Patients with Ankylosing Spondylitis: Clinical Trial and Post-Marketing Safety Analysis

    Atul A. Deodhar1, Corinne Miceli-Richard2, Xenofon Baraliakos3, Helena Marzo-Ortega4, Dafna D Gladman5, Ruvie Martin6, Jorge Safi7, Brian Porter7 and Abhijit Shete8, 1Oregon Health & Science University, Portland, OR, 2Rheumatology Department, Paris Descartes University, Paris, France, 3Ruhr-University Bochum, Herne, Germany, 4NIHR LBRC, LTHT and LIRMM, University of Leeds, Leeds, United Kingdom, 5Krembil Research Institute, Toronto Western Hospital, Toronto, ON, Canada, 6Novartis Pharmaceuticals Corporation, East Hanover, NJ, 7Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA, East Hanover, NJ, 8Novartis Pharma AG, Basel, Switzerland, Basel, Switzerland

    Background/Purpose: Uveitis, a common extra-articular manifestation of spondyloarthritis (SpA), has an estimated prevalence of 33.2% in patients with ankylosing spondylitis (AS), which increases with duration…
  • Abstract Number: 659 • 2018 ACR/ARHP Annual Meeting

    Comparison of MRI and Conventional Radiography for Detection of Structural Changes Typical for Spa – Data from the Assessment of Spondyloarthritis International Society Cohort

    Mikhail Protopopov1, Denis Poddubnyy2,3, Fabian Proft1, Stephanie Wichuk4, Pedro Machado5, Robert G. Lambert6, Ulrich Weber7,8, Susanne J Pedersen9,10, Mikkel Østergaard9,10, Joachim Sieper3, Martin Rudwaleit3,11, Xenofon Baraliakos12 and Walter P. Maksymowych13, 1Charité Universitätsmedizin Berlin, Berlin, Germany, 2German Rheumatism Research Centre, Berlin, Germany, 3Charité Universitätsmeidzin Berlin, Berlin, Germany, 4Medicine, Medicine, University of Alberta, Edmonton, AB, Canada, 5Centre for Rheumatology Research & MRC Centre for Neuromuscular Diseases, University College London, London, United Kingdom, 6Radiology, Radiology, University of Alberta, Edmonton, AB, Canada, 7University of Southern Denmark, Odense, Denmark, 8Rheumatology, King Christian 10th Hospital for Rheumatic Diseases, Graasten, Denmark, 9Copenhagen Center for Arthritis Research, Glostrup Hospital, University of Copenhagen, Copenhagen, Denmark, 10Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark, 11Internal Medicine and Rheumatology, Klinikum Bielefeld Rosenhöhe, Bielefeld, Germany, 12Rheumatology, Rheumazentrum Ruhrgebiet, Herne, and Ruhr University Bochum, Herne, Germany, 13University of Alberta, Edmonton, AB, Canada

    Background/Purpose: The objective of the study was to compare magnetic resonance imaging (MRI) and conventional radiography of the sacroiliac joints (SIJs) for detection of structural…
  • Abstract Number: 1147 • 2018 ACR/ARHP Annual Meeting

    Golimumab Improves Work Productivity and Activity Impairment in Patients with Rheumatoid Arthritis (RA), Ankylosing Spondylitis (AS) and Psoriatic Arthritis (PsA): 1-Year Results from a Non- Interventional Trial in Germany

    Klaus Krüger1, Sven Remstedt2, Astrid Thiele3 and Ines Klaudius4, 1Medical Centre of Rheumatology, Munich, Germany, 2Rheuma Praxis Berlin, Berlin, Germany, 3Krankenhaus St. Josef Wuppertal, Wuppertal, Germany, 4MSD Sharp & Dohme GmbH, Haar, Germany

    Background/Purpose: Non-interventional studies (NIS) are essential instruments in pharmaceutical research not only for pharmaceutical companies but also for regulatory authorities or reimbursement bodies in Germany.…
  • Abstract Number: 1654 • 2018 ACR/ARHP Annual Meeting

    Improvement of Cytological Grade and Tear Production in Ankylosing Spondylitis Patients Under Anti-TNF Therapy: A Long-Term Follow-up

    Fany Usuba1, Carla GS Saad2, Priscila Novaes1, Ruth Santo1, Julio CB Moraes2, Eloisa Bonfa3 and Milton Alves4, 1Ophtalmology Department, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil, 2Rheumatology Division, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil, 3Rheumatology Division, Hospital das Clinicas, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil, 4Ophtalmolgy Department, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil

    Background/Purpose: Clinical expression and pathophysiology of dry eye disease (DED) have recently changed and pro-inflammatory cytokines, such as TNF-α, may play a role in the…
  • Abstract Number: 2595 • 2018 ACR/ARHP Annual Meeting

    Golimumab Improves Socio- and Health Economic Parameters in Patients with RA, Psa and As: Real World-Data from a Non-Interventional Clinical Study in Germany

    Klaus Krüger1, Gerd R. Burmester2, Siegfried Wassenberg3, Valeria Biermann4 and Matthias H. Thomas5, 1Medical Centre of Rheumatology, Munich, Germany, 2Rheumatology and Clinical Immunology, Charité-University Medicine Berlin, Berlin, Germany, 3Rheumazentrum Ratingen, Ratingen, Germany, 4Lehrstuhl für Gesundheitsmanagement, Universität Erlangen-Nürnberg, Nürnberg, Germany, 5Medical Affairs, MSD Sharp & Dohme GmbH, Haar, Germany

    Background/Purpose: Golimumab (GLM) has shown its efficacy and safety in various clinical trials. Data from socio- and health economic parameters and costs in daily clinical…
  • Abstract Number: 660 • 2018 ACR/ARHP Annual Meeting

    Progression of Radiographic Sacroiliitis in Patients with Axial Spondyloarthritis from the Assessment of Spondyloarthritis International Society Cohort on Central Reading – Five-Year Data

    Mikhail Protopopov1, Fabian Proft1, Alexandre Sepriano2,3, Robert B.M. Landewé4,5, Désirée van der Heijde2, Joachim Sieper1, Martin Rudwaleit6,7 and Denis Poddubnyy1,8, 1Charité Universitätsmedizin Berlin, Berlin, Germany, 2Leiden University Medical Center, Leiden, Netherlands, 3Rheumatology, NOVA Medical School, Universidade Nova de Lisboa, Lisbon, Portugal, 4Zuyderland Medical Center, Heerlen, Netherlands, 5Amsterdam Rheumatology & Clinical Immunology Center, Amsterdam, Netherlands, 6Charité Universitätsmeidzin Berlin, Berlin, Germany, 7Rheumatology, Klinikum Bielefeld Rosenhöhe, Berlin, Germany, 8German Rheumatism Research Centre, Berlin, Germany

    Background/Purpose: It is known that radiographic progression of sacroiliitis in axial spondyloarthritis (axSpA) is quite slow, with only few predictors of such progression identified. An…
  • Abstract Number: 1189 • 2018 ACR/ARHP Annual Meeting

    Secukinumab Versus Adalimumab for the Treatment of Ankylosing Spondylitis: A Cost per Responder Analysis from Korean Perspective

    Dam Kim1, Hyojin Kim2, Seongha Cho2 and Min-Chan Park1, 1Division of Rheumatology, Department of Internal Medicine, Yonsei University College of Medicine, Gangnam Severance Hospital, Seoul, Korea, Republic of (South), 2Patient Access Team, Novartis Korea, Seoul, Korea, Republic of (South)

    Secukinumab versus Adalimumab for the Treatment of Ankylosing Spondylitis: A Cost per Responder Analysis from Korean PerspectiveDam Kim1, Hyojin Kim2, SeongHa Cho2, Min-Chan Park11Division of…
  • Abstract Number: 1830 • 2018 ACR/ARHP Annual Meeting

    Role of BMP2 in Entheseal Bone Formation in Inflammatory Arthritis

    Yukiko Maeda1, Jozsef Karman2 and Ellen M. Gravallese3, 1Medicine, University of Massachusetts Medical School, Worcester, MA, 2Abbvie Bioresearch Center, Worcester, MA, 3Lazare Research Bldg, University of Massachusetts Medical School, Worcester, MA

    Background/Purpose: Spondyloarthritis (SpA) is common, with a prevalence of ~1% in the United States. Patients with SpA suffer from pain and disability due to inflammation…
  • « Previous Page
  • 1
  • …
  • 38
  • 39
  • 40
  • 41
  • 42
  • …
  • 67
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology